Cross-sectoral pharmacotherapeutic coherence in the Netherlands

Author:

Fijn R1,Brouwers J R B J2,De Van den Berg L T W Jong1

Affiliation:

1. Department of Social Pharmacy and Pharmacoepidemiology, Groningen University Institute for Drug Exploration, University of Groningen, Antonius Deusinglaan 2, 9713 AW Groningen, The Netherlands

2. Department of Clinical Pharmacology and Hospital Pharmacy, General Hospital De Tjongerschans, Heerenveen, The Netherlands

Abstract

AbstractObjectivesTo measure the extent of pharmacotherapeutic coherence across sectors of Dutch health care from the hospitals' perspective, and to identify perceived markers of coherence and barriers to improvementMethodsTelephone interviews were carried out with hospital pharmacists (76), community pharmacists (5), and clinical pharmacologists (9) affiliated to pharmacies serving 120 Dutch general hospitals. Coherence between (a) hospital and general practice, (b) hospital and nursing home practice, (c) hospitals, and (d) hospital inpatient and outpatient practice was reported and assessed against a set of indicatorsResultsAlmost all hospitals (93 per cent) had formulary agreements or prescribing policies in place and 86 per cent of these had a printed hospital drug formulary (HDF). Over 50 per cent of hospitals reported that they had established coherence with nursing home practice and/or with other hospitals. Less than half of the hospitals had established coherence with general practice. Few hospitals reported activities to review outpatient prescribing and its implications for follow-on prescribing in primary care. Reported barriers to increasing coherence could be classed into three categories: economic, organisational and social. Suggestions to enhance coherence included influencing professionals' practice through training, and greater use of regional and national policies on prescribingConclusionTherapeutic coherence within Dutch health care is far from ideal. The discrepancy between the actual and desired extent of coherence arises from organisational and economic barriers. To date, activities in this area have relied on professional proactivity rather than a structured approach. To move forward, (dis)incentives should be created for health care providers and professionals across all sectors, including pharmacists and prescribers

Publisher

Oxford University Press (OUP)

Subject

Public Health, Environmental and Occupational Health,Health Policy,Pharmaceutical Science,Pharmacy

Reference53 articles.

1. Economic aspects of drug therapy in hospitals: an issue for clinical pharmacologists;Harder;Int J Clin Pharmacol Ther,1994

2. Pharmacists as agents of change for rational drug therapy;Levens-Lipton;Int J Technol Ass Health Care,1995

3. Pharmacy involvement in formulary development: community pharmacists' views;Hughes;Int J Pharm Pract,1996

4. The pharmacist's contribution to medical audit: perceptions of doctors and pharmacists in the North West Thames Regional Health Authority;Harris;J Soc Adm Pharm,1993

5. The involvement of pharmacists in professional and clinical audit in the UK: a review and assessment of their potential role;Panton;J Eval Clin Pract,1996

Cited by 3 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3